טוען...
Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease
IMPORTANCE: While cladribine is best known for the treatment of hairy cell leukemia and other lymphoid cancers, it also has activity against myeloid neoplasms, such as Erdheim-Chester disease (ECD). OBJECTIVE: To assess the efficacy of cladribine (2-chloro-2′-deoxyadenosine) in the treatment of ECD....
שמור ב:
| הוצא לאור ב: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Medical Association
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824289/ https://ncbi.nlm.nih.gov/pubmed/28253394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.0041 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|